Clinical trials
Completed Observational Autistic Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 7 |
| 2014 | 2 |
| 2015 | 8 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 8 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 89 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 6 |
| National Institute of Mental Health (NIMH) | 5 |
| Boston Children's Hospital | 3 |
| Cairo University | 2 |
| EarliTec Diagnostics, Inc | 2 |
| Icahn School of Medicine at Mount Sinai | 2 |
| Johns Hopkins University | 2 |
| National Taiwan University Hospital | 2 |
| SynapDx | 2 |
| The Cleveland Clinic | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autistic Disorder | 89 |
| Autism Spectrum Disorder | 43 |
| Asperger Syndrome | 8 |
| Child Development Disorders, Pervasive | 6 |
| Learning Disabilities | 6 |
| Neurodevelopmental Disorders | 5 |
| Anxiety Disorders | 4 |
| Mental Disorders | 4 |
| Schizophrenia | 4 |
| Developmental Disabilities | 3 |
Trials
Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.